---
figid: PMC10310293__nihms-1909005-f0002
pmcid: PMC10310293
image_filename: nihms-1909005-f0002.jpg
figure_link: /pmc/articles/PMC10310293/figure/F2/
number: Figure 2
figure_title: ''
caption: HER2 signaling pathway is activated by dimerization of HER2 to another protein.
  Trastuzumab targets the binding domain of HER2 and inhibits dimerization, thus blocking
  the cell signaling pathway. (Image created in BioRender.com)
article_title: 'Advanced breast cancer metastasized in the brain: treatment standards
  and innovations.'
citation: Elizabeth Klaas, et al. J Cancer Metastasis Treat. ;9:23.
year: '2023'

doi: 10.20517/2394-4722.2022.125
journal_title: Journal of cancer metastasis and treatment
journal_nlm_ta: J Cancer Metastasis Treat
publisher_name: ''

keywords:
- Breast cancer
- innovation
- blood-brain barrier
- luminal metastasis
- new directions

---
